Index falls as earnings results weigh; pound above $1.33, Bodycote soars
Investing.com - Xilio Development reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Xilio Development announced earnings per share of $-0.72 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.79 on revenue of $0.00.
Xilio Development 's are down 0.45% and is trading at $2.34 , still down 91.63% from its 52 week high of $27.95 set on Tuesday, November 16, 2021.
Xilio Development shares gained 1.30% to trade at $2.34 in intra-day trade the report.
Xilio Development follows other major Healthcare sector earnings this month
Xilio Development's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar